FDA grants emergency use authorization for COVID-19 drug [View all]
Source: Scripps News
Posted: 5:57 p.m. EDT Mar 26, 2024
There’s a new drug to help the fight against COVID-19. Pemgarda, made by Invivyd, is an infusion drug made for those who are immunocompromised to help support the immune system in preventing COVID-19 infection.
The Food and Drug Administration granted an emergency use authorization for high-risk patients 12 years and older on March 22. Individuals must also weigh 88 pounds to use the drug.
The FDA wrote in the announcement that this treatment is authorized for those who “have moderate-to-severe immune compromise due to a medical condition or due to taking immunosuppressive medications or treatments and are unlikely to mount an adequate immune response to COVID-19 vaccination.”
This could include cancer patients or those who received an organ transplant, for example. Qualified individuals can get the monoclonal antibody infusion once every three months at most. No cost was mentioned in the company’s press release.
Read more: https://scrippsnews.com/stories/fda-grants-emergency-use-authorization-for-covid-19-drug/
Link to FDA PRESS RELEASE - https://www.fda.gov/news-events/press-announcements/fda-roundup-march-22-2024
= new reply since forum marked as read